Product code KLR— Clinical Toxicology
ADVANCE EMIT CAD DISOPYRAMIDE ASSAY
- Classification name
- Enzyme Immunoassay, Lidocaine
- Device class
- Class 2
- Regulation
- 21 CFR 862.3555
- Advisory panel
- Clinical Toxicology
- Total cleared
- 17
- First cleared
- Most recent
Market context for product code KLR
FDA has cleared devices under product code KLR between 1980 and 2009, filed by 11 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2009
- 2004
- 1997
- 1988
- 1985
- 1984
- 1983
- 1982
- 1980
Top applicants under product code KLR
Recent clearances under product code KLR
- K090282 — QMS LIDOCAINE
- K033809 — DIMENSION LIDOCAINE (LIDO) FLEX REAGENT CARTRIDGE METHOD, DIMENSION DRUG CALIBRATOR II, MODELS DF113. DC49D
- K032334 — ROCHE ONLINE TDM LIDOCAINE
- K973102 — LIDOCAINE EIA ASSAY
- K881116 — EASY-TEST EMIT(R) LIDOCAINE LIDO ITEM NO. 16641
- K853010 — COBAS REAGENT FOR LIDOCAINE & CALIBRATORS
- K843184 — STRATUS LIDOCAINE FLUOROMETRIC ENZYME
- K833379 — LIDOCAINE ANALYTICAL TEST PACK ACA
- K833381 — VALPROIC ACID ANALYTICAL TEST PACK
- K833623 — MODIF. OF EMIT CAD DISOPYRAMIDE ASSAY
- K832799 — MODIFICA- OF EMIT CAD LIDOCAINE ASSAY
- K831354 — EMIT QST LIDOCAINE ASSAY
- K823887 — ADVANCE EMIT CAD DISOPYRAMIDE ASSAY
- K823866 — ADVANCE EMIT CAD LIDOCAINE ASSAY
- K822347 — LIDOCAINE FLUORESCENT IMMUNOASSAY
- K802131 — CYBREX LIDOCAINE
- K801204 — EMIT DISOPYRAMIDE ASSAY
Data sourced from openFDA. This site is unofficial and independent of the FDA.